海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Full dose S1 compared to reduced dose S-1/oxaliplatin. First-line treatment for older patients with metastic colorectal cancer.
- Treatment of older (= 70 years) patients with metastatic colorectal cancer MedDRA version: 20.0 Level: PT Classification code 10052358 Term: Colorectal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Denmark, Finland, Norway
- 2014-03-05
Authorised
- Mechanism of action study of anti-IL17 treatment in spondyloarthritis.
- Spondyloarthritis MedDRA version: 16.1 Level: LLT Classification code 10032155 Term: Other inflammatory spondylopathies System Organ Class: 100000004859 MedDRA version: 16.1 Level: LLT Classification code 10070759 Term: Spondylopathy System Organ Class: 100000004859 ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Netherlands
- 2014-01-16
Authorised
- Impact of treatment with Dapagliflozin in type 1 diabetic patients
- Type 1 diabetes MedDRA version: 18.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Spain
- 2015-07-31
Authorised
- Phase 4 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
- Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma MedDRA version: 20.0 Level: HLT Classification code 10002235 Term: Anaplastic large cell lymphomas T- and null-cell types System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Croatia, Czech Republic, Hungary, Poland, Portugal, Romania, Spain, Turkey, United Kingdom
- 2013-04-15
Authorised
- Infliximab as first treatment instead of second line treatment in Crohns disease
- Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Belgium, Italy, Netherlands
- 2012-07-12
Authorised
- Estudio farmacogenético fase II randomizado para evaluar la eficacia y seguridad del esquema FOLFIRI con altas dosis de irinotecán (FOLFIRI-AD) en pacientes con cáncer colorrectal metastásico de acuerdo con el genotipo UGT1A 1
- metastatic colorectal cancer;Therapeutic area: Diseases [C] - Cancer [C04]
- Spain
- 2012-03-09
Authorised
- A Phase 1/2 study to test how effective different doses of MEDI-551 is for treating subjects with Relapsing-Remitting Multiple Sclerosis
- Relapsing-Remitting Multiple Sclerosis MedDRA version: 14.1 Level: PT Classification code 10063399 Term: Relapsing-remitting multiple sclerosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Austria, Canada, Czech Republic, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, United States
- 2012-03-05
Authorised
- A 1-year study to compare long-acting insulin therapies in patients with type 2 diabetes
- Type 2 Diabetes Mellitus MedDRA version: 14.1 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Czech Republic, Germany, Greece, Israel, Romania, Russian Federation, Spain, United States
- 2012-02-28
Authorised
- The REMOVAL study: metformin in type 1 diabetes
- People with type 1 diabetes with risk factors for cardiovascular disease MedDRA version: 14.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
- Australia, Canada, Denmark, Netherlands, United Kingdom
- 2011-08-17
Authorised
- S-1 (Teysuno) versus capecitabine with or without bevacizumab, as first line treatment in patients with metastazised bowel cancer. A study of the Duthch colorectal Cancer Group.
- Metastatic Colorectal Cancer MedDRA version: 17.1 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Netherlands
- 2013-06-18
